Detection of 3-iodothyronamine in human patients: A preliminary study

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 1, 2012, Pages

  Galli, Elena ^a   Marchini, Maja ^b   Saba, Alessandro ^b   Berti, Sergio ^c   Tonacchera, Massimo ^b   Vitti, Paolo ^b   Scanlan, Thomas S ^d   Iervasi, Giorgio ^e   Zucchi, Riccardo ^b  

^a SCUOLA SUPERIORE SANT ANNA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c Ospedale del Cuore   (Italy)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e Istituto di Fisiologia Clinica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 IODOTHYRONAMINE; BIOGENIC AMINE; BRAIN NATRIURETIC PEPTIDE; GAMMA GLUTAMYLTRANSFERASE; GLYCOSYLATED HEMOGLOBIN; LEVOTHYROXINE; UNCLASSIFIED DRUG;

ADULT; AMBULATORY CARE; ARTICLE; ATHYREOSIS; BLOOD SAMPLING; CARDIOLOGY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISORDERS OF HORMONE METABOLISM; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEMATOLOGY; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HOSPITAL ADMISSION; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRELIMINARY COMMUNICATION; PRIORITY JOURNAL; THYROID DISEASE;

BLOOD CHEMICAL ANALYSIS; CARDIOVASCULAR DISEASES; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PATIENTS; PILOT PROJECTS; RISK FACTORS; THYROID FUNCTION TESTS; THYRONINES;

ANIMALIA;

EID: 84855514921     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1115     Document Type: Article

References (22)

1. Scanlan TS, Suchland KL, Hart ME, Chiellini G, Huang Y, Kruzich PJ, Frascarelli S, Crossley DA, Bunzow JR, Ronca-Testoni S, Lin ET, Hatton D, Zucchi R, Grandy DK 2004 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat Med 10:638-642
2. Snead AN, Santos MS, Seal RP, Miyakawa M, Edwards RH, Scanlan TS 2007 Thyronamines inhibit plasma membrane and vescicular monoamine transport. ACS Chem Biol 2:390-398
3. Frascarelli S, Ghelardoni S, Chiellini G, Vargiu R, Ronca-Testoni S, Scanlan TS, Grandy DK, Zucchi R 2008 Cardiac effects of trace amines: pharmacological characterization of trace amine associated receptors. Eur J Pharmacol 587:231-236
4. 1 ATP synthase. Biochim Biophys Acta Bioenergetics 1797(Suppl 1):29 (Abstract)
5. Ianculescu AG, Friesema EC, Visser TJ, Giacomini KM, Scanlan TS 2010 Transport of thyroid hormones is selectively inhibited by 3-iodothyronamine. Mol BioSyst 6:1403-1410
6. Zucchi R, Chiellini G, Scanlan TS, Grandy DK 2006 Trace amine-associated receptors and their ligands. Br J Pharmacol 149:967-978
7. 1AM): a new chapter of thyroid hormone endocrinology? Mol BioSyst 6:1338-1344
8. Piehl S, Hoefig CS, Scanlan TS, Köhrle J 2011 Thyronamines - past, present, and future. Endocr Rev 32:64-80
9. Chiellini G, Frascarelli S, Ghelardoni S, Carnicelli V, Tobias SC, DeBarber A, Brogioni S, Ronca-Testoni S, Cerbai E, Grandy DK, Scanlan TS, Zucchi R 2007 Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function. FASEB J 21:1597-1608
10. Ghelardoni S, Suffredini S, Frascarelli S, Brogioni S, Chiellini G, Ronca-Testoni S, Grandy DK, Scanlan TS, Cerbai E, Zucchi R 2009. Modulation of cardiac ionic homeostasis by 3-iodothyronamine. J Cell Mol Med 13:3082-3090
11. Braulke LJ, Klingenspor M, DeBarber A, Tobias SC, Grandy DK, Scanlan TS, Heldmaier G 2008 3-Iodothyronamine: a novel hormone controlling the balance between glucose and lipid utilisation. J Comp Physiol B 178:167-177
12. Regard JB, Kataoka H, Cano DA, Camerer E, Yin L, Zheng YW, Scanlan TS, Hebrok M, Coughlin SR 2007 Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion. J Clin Invest 117:4034-4043
13. Klieverik LP, Foppen E, Ackermans MT, Serlie MJ, Sauerwein HP, Scanlan TS, Grandy DK, Fliers E, Kalsbeek A 2009 Central effects of thyronamines on glucose metabolism in rats. J Endocrinol 201:377-386
14. Dhillo WS, Bewick GA, White NE, Gardiner JV, Thompson EL, Bataveljic A, Murphy KG, Roy D, Patel NA, Scutt JN, Armstrong A, Ghatei MA, Bloom SR 2009 The thyroid hormone derivative 3-iodothyronamine increases food intake in rodents. Diabetes Obes Metab 11:251-260
15. Hettinger BD, Schuff K, Marks D, Scanlan TS 2010 3-Iodothyronamine (T1AM) causes weight loss in mice via reduction in food consumption. Proc of the 14th International Thyroid Congress, Paris, France, OC-141 (Abstract)
16. Gu J, Soldin SP, Soldin SJ 2010 Development and validation of an isotope dilution tandem mass spectrometry method for simultaneous quantification of 3-iodothyronamine, thyroxine, triiodothyronine, and 3,3′-diiodo-L- thyronine. Clin Chem 56:A60 (Abstract).
17. 6-thyroxine. J Endocrinol 206:327-334
18. Saba A, Chiellini G, Frascarelli S, Marchini M, Ghelardoni S, Raffaelli A, Tonacchera M, Vitti P, Scanlan TS, Zucchi R 2010 Tissue distribution and cardiac metabolism of 3-iodothyronamine. Endocrinology 151:5063-5073
19. Kratzsch J, Schubert G, Pulzer F, Pfaeffle R, Koerner A, Dietz A, Rauh M, Kiess W, Thiery J 2008 Reference intervals for TSH and thyroid hormones are mainly affected by age, body mass index and number of blood leucocytes, but hardly by gender and thyroid autoantibodies during the first decades of life. Clin Biochem 41:1091-1098
20. Hoefig CS, Köhrle J, Brabant G, Dixit K, Yap B, Strasburger CJ, Wu Z 2011 Evidence for extrathyroidal formation of 3-iodothyronamine in humans as provided by a novel monoclonal antibodybased chemiluminescent serum immunoassay. J Clin Endocrinol Metab 96:1864-1872
21. 1AM): more than we bargained for. J Clin Endocrinol Metab 96:1674-1676
22. Soldin SJ, Cheng LL, Lam LY, Werner A, Le AD, Soldin OP 2010 Comparison of FT4 with log TSH on the Abbott Architect ci8200: pediatric reference intervals for free thyroxine and thyroid-stimulating hormone. Clin Chim Acta 411:250-252